Acadia Healthcare Company, Inc. (NASDAQ:ACHC) Receives Consensus Recommendation of “Hold” from Brokerages

Acadia Healthcare Company, Inc. (NASDAQ:ACHC) has earned an average recommendation of “Hold” from the fifteen ratings firms that are presently covering the stock, MarketBeat reports. Three investment analysts have rated the stock with a sell rating, six have assigned a hold rating and six have assigned a buy rating to the company. The average 1-year price objective among brokers that have covered the stock in the last year is $18.6154.

A number of analysts have recently weighed in on ACHC shares. TD Cowen reiterated a “reduce” rating on shares of Acadia Healthcare in a report on Friday, January 16th. Cantor Fitzgerald set a $17.00 price objective on Acadia Healthcare in a report on Wednesday, December 3rd. Weiss Ratings reissued a “sell (d)” rating on shares of Acadia Healthcare in a research note on Wednesday, January 21st. Jefferies Financial Group lowered Acadia Healthcare to a “hold” rating in a research note on Thursday, January 22nd. Finally, Raymond James Financial set a $17.00 price objective on shares of Acadia Healthcare in a research report on Wednesday, December 3rd.

Acadia Healthcare Price Performance

Shares of Acadia Healthcare stock opened at $13.44 on Friday. The company has a debt-to-equity ratio of 0.73, a current ratio of 1.44 and a quick ratio of 1.44. Acadia Healthcare has a one year low of $11.43 and a one year high of $45.47. The business’s 50 day simple moving average is $14.35 and its two-hundred day simple moving average is $19.28. The stock has a market capitalization of $1.24 billion, a P/E ratio of 11.49, a price-to-earnings-growth ratio of 3.71 and a beta of 0.88.

Acadia Healthcare (NASDAQ:ACHC) last issued its earnings results on Wednesday, November 5th. The company reported $0.72 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.71 by $0.01. Acadia Healthcare had a net margin of 3.29% and a return on equity of 7.66%. The firm had revenue of $851.57 million for the quarter, compared to analysts’ expectations of $852.43 million. During the same quarter last year, the business earned $0.91 earnings per share. The business’s revenue was up 4.4% on a year-over-year basis. Acadia Healthcare has set its FY 2025 guidance at 2.350-2.450 EPS. Analysts forecast that Acadia Healthcare will post 3.38 EPS for the current year.

Institutional Trading of Acadia Healthcare

Several large investors have recently bought and sold shares of the company. Envestnet Portfolio Solutions Inc. boosted its position in shares of Acadia Healthcare by 256.4% during the second quarter. Envestnet Portfolio Solutions Inc. now owns 26,053 shares of the company’s stock valued at $591,000 after purchasing an additional 18,742 shares in the last quarter. Oppenheimer Asset Management Inc. increased its stake in shares of Acadia Healthcare by 85.1% during the second quarter. Oppenheimer Asset Management Inc. now owns 28,683 shares of the company’s stock valued at $651,000 after purchasing an additional 13,188 shares in the last quarter. Janney Montgomery Scott LLC purchased a new position in shares of Acadia Healthcare during the second quarter valued at approximately $479,000. First Citizens Bank & Trust Co. boosted its position in shares of Acadia Healthcare by 164.1% in the 3rd quarter. First Citizens Bank & Trust Co. now owns 59,123 shares of the company’s stock worth $1,464,000 after purchasing an additional 36,733 shares in the last quarter. Finally, Caxton Associates LLP grew its stake in shares of Acadia Healthcare by 1,234.5% in the 2nd quarter. Caxton Associates LLP now owns 173,482 shares of the company’s stock worth $3,936,000 after buying an additional 160,482 shares during the last quarter.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc (NASDAQ: ACHC) is a publicly traded provider of behavioral healthcare services headquartered in Franklin, Tennessee. Founded in 2005, the company has grown through organic expansion and strategic acquisitions to establish itself as a leading specialist in mental health and addiction treatment across the United States.

Acadia operates a diversified network of inpatient psychiatric hospitals, residential treatment centers, outpatient clinics and intensive outpatient programs.